Exploring the impact on patients with lupus and related autoimmune diseases of peer support, relationships with clinicians and COVID-19 changes to care

Not Applicable

Completed

• Conditions: upus and other related SARDs/CTDs (systemic autoimmune rheumatic diseases/connective tissue diseases); Skin and Connective Tissue Diseases; Lupus erythematosus

• Registration Number: ISRCTN14966097
• Lead Sponsor: niversity of Cambridge

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/34995345/ (added 10/01/2022) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33604501/ (added 28/03/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/34698822/ (added 28/03/2023) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33728396/ (added 28/03/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-27
• Study Completion: 2021-04-01
• Last Update Posted: 10 April 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 139

Inclusion Criteria

1. Participants with a self-verified diagnosis of SLE, UCTD, Sjögren’s syndrome, discoid/cutaneous lupus or MCTD/overlap disease
2. Resident in the UK
3. Participants aged 18 or over

Exclusion Criteria

Patients with significant cognitive impairment and unable to undertake informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified